BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21148311)

  • 1. 14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53.
    Lee JH; Lu H
    J Biol Chem; 2011 Feb; 286(7):5136-42. PubMed ID: 21148311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.
    Jin Y; Dai MS; Lu SZ; Xu Y; Luo Z; Zhao Y; Lu H
    EMBO J; 2006 Mar; 25(6):1207-18. PubMed ID: 16511572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.
    Jin Y; Zeng SX; Sun XX; Lee H; Blattner C; Xiao Z; Lu H
    Mol Cell Biol; 2008 Feb; 28(4):1218-29. PubMed ID: 18086887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein.
    Lee JH; Jin Y; He G; Zeng SX; Wang YV; Wahl GM; Lu H
    J Biol Chem; 2012 Jun; 287(25):20898-903. PubMed ID: 22556425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.
    LeBron C; Chen L; Gilkes DM; Chen J
    EMBO J; 2006 Mar; 25(6):1196-206. PubMed ID: 16511560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.
    He G; Zhang YW; Lee JH; Zeng SX; Wang YV; Luo Z; Dong XC; Viollet B; Wahl GM; Lu H
    Mol Cell Biol; 2014 Jan; 34(2):148-57. PubMed ID: 24190973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
    He G; Siddik ZH; Huang Z; Wang R; Koomen J; Kobayashi R; Khokhar AR; Kuang J
    Oncogene; 2005 Apr; 24(18):2929-43. PubMed ID: 15735718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.
    Gerarduzzi C; de Polo A; Liu XS; El Kharbili M; Little JB; Yuan ZM
    J Biol Chem; 2016 Dec; 291(50):25937-25949. PubMed ID: 27777309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
    Wang X
    Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.
    Zhang Z; Wang H; Li M; Agrawal S; Chen X; Zhang R
    J Biol Chem; 2004 Apr; 279(16):16000-6. PubMed ID: 14761977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells.
    Melkoumian ZK; Peng X; Gan B; Wu X; Guan JL
    Cancer Res; 2005 Aug; 65(15):6676-84. PubMed ID: 16061648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage-induced MDMX degradation is mediated by MDM2.
    Kawai H; Wiederschain D; Kitao H; Stuart J; Tsai KK; Yuan ZM
    J Biol Chem; 2003 Nov; 278(46):45946-53. PubMed ID: 12963717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 promotes ubiquitination and degradation of MDMX.
    Pan Y; Chen J
    Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells.
    Luo D; Yu C; Yu J; Su C; Li S; Liang P
    Cell Cycle; 2022 Jan; 21(2):140-151. PubMed ID: 34878965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of how stress-induced MDMX phosphorylation activates p53.
    Chen X; Gohain N; Zhan C; Lu WY; Pazgier M; Lu W
    Oncogene; 2016 Apr; 35(15):1919-25. PubMed ID: 26148237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.